Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (85)
Wnt signaling and cancer
2000 • 3,215 citations
A molecular mechanism for the effect of lithium on development.
1996 • 2,270 citations
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen
2001 • 1,684 citations
The renaissance of GSK3
2001 • 1,459 citations
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 • 1,408 citations
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
2000 • 1,365 citations
Molecular cloning and expression of glycogen synthase kinase-3/factor A.
1990 • 1,329 citations
Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells
1996 • 1,299 citations
GSK3 takes centre stage more than 20 years after its discovery
2001 • 1,298 citations
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin
1998 • 1,244 citations
GSK3 takes centre stage more than 20 years after its discovery
2001 • 939 citations
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
2000 • 867 citations
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
1999 • 784 citations
Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease
2001 • 685 citations
A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylation
2001 • 679 citations
Crystal Structure of Glycogen Synthase Kinase 3β
2001 • 636 citations
The role of protein phosphorylation in human health and disease.
2001 • 596 citations
The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus
1999 • 485 citations
Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium
2001 • 482 citations
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
1997 • 459 citations
Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine
1992 • 454 citations
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
2000 • 434 citations
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
2002 • 430 citations
Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent
2000 • 419 citations
Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B
1993 • 399 citations
Glucose Sensing in Pancreatic β-Cells
2001 • 396 citations
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
2000 • 390 citations
Structure of GSK3beta reveals a primed phosphorylation mechanism.
2001 • 368 citations
Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β
2000 • 361 citations
Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
2000 • 361 citations
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
2001 • 361 citations
Spatial learning deficit in transgenic mice that conditionally over‐express GSK‐3β in the brain but do not form tau filaments
2002 • 360 citations
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
2000 • 344 citations
The Molecular Bases of Alzheimer's Disease and Other Neurodegenerative Disorders
2001 • 337 citations
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
1997 • 315 citations
Paullones, a Series of Cyclin-Dependent Kinase Inhibitors: Synthesis, Evaluation of CDK1/Cyclin B Inhibition, and in Vitro Antitumor Activity
1999 • 314 citations
Judging a Protein by More Than Its Name: GSK-3
2001 • 281 citations
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
1999 • 269 citations
Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
1999 • 219 citations
GSK3, a master switch regulating cell-fate specification and tumorigenesis
2000 • 219 citations
Inhibition of GSK-3 Selectively Reduces Glucose-6-Phosphatase and Phosphoenolpyruvate Carboxykinase Gene Expression
2001 • 215 citations
The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation
2001 • 194 citations
Phosphorylation of human tau protein by microtubule-associated kinases: GSK3? and cdk5 are key participants
2000 • 173 citations
Current Therapies and Emerging Targets for the Treatment of Diabetes
2001 • 167 citations
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)
2001 • 156 citations
Lithium therapy and signal transduction
2000 • 155 citations
Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations
1999 • 154 citations
Glycogen Synthase Kinase 3β Negatively Regulates Both DNA-binding and Transcriptional Activities of Heat Shock Factor 1
2000 • 154 citations
Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers
2001 • 141 citations
The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31‐8220) are potent inhibitors of glycogen synthase kinase‐3 activity
1999 • 140 citations
Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest
2001 • 134 citations
A Structure-Based Library Approach to Kinase Inhibitors
1996 • 125 citations
Neurofibrillary tangles and tau phosphorylation
2001 • 123 citations
Low GSK-3 activity in frontal cortex of schizophrenic patients
2001 • 123 citations
Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase
2001 • 119 citations
Identification of the Axin and Frat Binding Region of Glycogen Synthase Kinase-3
2002 • 113 citations
Expression analysis of glycogen synthase kinase‐3 in human tissues
1999 • 112 citations
Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+deprivation in cerebellar granule cells
2001 • 99 citations
Integrin-linked kinase (ILK): a “hot” therapeutic target
2000 • 98 citations
Glycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels
2001 • 98 citations
GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity
2001 • 87 citations
Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death
2001 • 84 citations
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons
2000 • 83 citations
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors
2000 • 77 citations
Therapeutic Strategies in Alzheimer’s Disease: Ml Muscarinic Agonists
2000 • 74 citations
Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter
1999 • 68 citations
M1 Muscarinic Agonists as Potential Disease‐Modifying Agents in Alzheimer's Disease: Rationale and Perspectives
2000 • 62 citations
Phosphorylation of tau by glycogen synthase kinase 3β in intact mammalian cells influences the stability of microtubules
2001 • 60 citations
Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 β gene and promoter in late onset Alzheimer's disease
2001 • 60 citations
Missing Links in GSK3 Regulation
2001 • 59 citations
The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB.
1997 • 57 citations
Lithium-related genetics of bipolar disorder
2001 • 46 citations
Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimers Disease
2002 • 40 citations
Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders
2000 • 39 citations
Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds
1999 • 38 citations
Inhibition of voltage‐dependent sodium channels by Ro 31‐8220, a ‘specific’ protein kinase C inhibitor
2000 • 34 citations
Glycogen synthase kinase 3 phosphorylation of different residues in the presence of different factors: Analysis on tau protein
1996 • 33 citations
Different expression of glycogen synthase kinase-3βbetween young and old rat brains after transient middle cerebral artery occlusion
2001 • 33 citations
Synthese von 7,12‐Dihydro‐indolo[3,2‐d][1]benzazepin‐6‐(5H)‐onen und 6,11‐Dihydro‐thieno‐[3′,2′:2,3]azepino[4,5‐b]indol‐5(4H)‐on
1992 • 32 citations
The interaction between β-catenin, GSK3β and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer
2001 • 23 citations
Reactions of N‐Alkyl‐ and N‐Aryl‐S‐chloroisothiocarbamoyl Chlorides with Isocyanates; Synthesis of 1,2,4‐Thiadiazolidine‐3,5‐diones
1966 • 16 citations
Arylimino-1,2,4-thiadiazolidinones: A new family of potassium channel openers
1997 • 16 citations
Experimentally Induced Benignancy of Neoplasm. V. The Influence of Hormones on the Host's Resistance to Implanted Neoplasm
1941 • 10 citations
Traditional and Modern Medicine
2016 • 6 citations
Glycogen synthase kinase-3beta as a target for anti-apoptotic signals
2001 • 1 citations